Linear Clinical Research has been recognised with two awards in the Innovation and Marketing categories in the 2024 Clinical Trials Arena Excellence Awards for its transformative impact on clinical trials.
The Clinical Trials Arena Excellence Awards celebrate the greatest achievements and innovations in the pharmaceutical clinical trials industry. Powered by GlobalData’s business intelligence, the Awards recognise the people and companies that are driving change in the industry.
Linear Clinical Research won the Innovation award for its significant improvements in cohort randomisation rates and the implementation of a near real-time study dashboard, enhancing trial efficiency. The company secured the Marketing award by achieving a substantial reduction in participant acquisition costs through optimised marketing strategies and effective channel prioritisation.
Innovation in clinical trials: Advanced recruitment analytics
Linear Clinical Research has significantly improved cohort randomisation rates, achieving an impressive 94% on-time completion in 2024. This remarkable advancement from previous years’ 80% completion rate demonstrates Linear’s efforts to enhance trial efficiency. By leveraging accurate recruitment projections based on meticulous analysis of study protocols and historical data, Linear has optimised planning and resource allocation, ensuring that each trial phase is adequately supported.
A cornerstone of this achievement is the development of a near real-time study dashboard, which provides critical insights into recruitment status and cohort enrollment progress. The innovative tool empowers Linear to make real-time adjustments to recruitment strategies, ensuring that participant numbers align with study requirements. The data-driven approach adopted by Linear has created a more agile and responsive system, facilitating seamless execution of clinical trials. It benefits sponsors by providing faster and more predictable project timelines. Additionally, it enhances the overall reliability of the trial process.
Marketing excellence: Cost-efficient participant recruitment
Linear Clinical Research has achieved significant improvements in marketing efficiency by achieving a 66% reduction in participant acquisition costs in 2024. This achievement reflects a transformative improvement in marketing strategies, as evidenced by an 80.8% reduction in the average cost per acquisition (CPA) from 2022 to 2024. Linear’s marketing team has meticulously optimised campaigns through strategic analysis, A/B testing, and performance tracking, ensuring cost-effective lead generation.
By prioritising the correct channels based on participant engagement analysis, Linear has successfully reallocated budgets to platforms that deliver the best results, thereby enhancing return on investment (ROI). The company’s optimal marketing mix, which combines digital and traditional techniques, has maintained a steady participant pipeline. Marketing campaigns on platforms such as Google, Facebook, and Instagram, along with email automation and SEO enhancements, contributed to this achievement. These strategic adjustments have enabled Linear to drive down costs while maintaining participant quality, supporting the success of multiple clinical trials and securing a competitive edge in the industry.
“Winning Clinical Trials Arena Excellence Awards for Innovation and Marketing Strategies highlights Linear’s strong commitment to excellence and innovation in clinical trials. Our success in optimising participant recruitment and cohort randomisation reflects the dedication and creativity of our team. By using data-driven strategies and advanced tools, we have improved trial speed, and efficiency and shown our ability to create significant change for our sponsors and the broader healthcare community. These awards reinforce our vision of advancing “Human Breakthroughs” by pushing boundaries in clinical research. We are extremely proud to be recognised among the industry’s best.”
– Jayden Rogers, CEO
Company Profile
Linear Clinical Research is an innovative clinical trial organisation based in Perth, Western Australia. Linear has completed over 500 trials for international biopharma since its formation in 2010 across a wide range of therapeutic areas. With three state-of-the-art clinical facilities, Linear can support the execution of all trial phases with a key focus on delivering your study as fast as possible without compromising on quality and data integrity.
Contact Details
E-mail: enquiries@linear.org.au
Phone: +61 (08) 6382 5100
Address: 174 Hampden Road, Nedlands, Western Australia 6009
Links
Website: https://www.linear.org.au/
